
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18477134
[patent_doc_number] => 11690858
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-07-04
[patent_title] => Neuroprotective mixture for mitigating the harmful effects of ischemic stroke
[patent_app_type] => utility
[patent_app_number] => 17/099293
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 4075
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099293 | Neuroprotective mixture for mitigating the harmful effects of ischemic stroke | Nov 15, 2020 | Issued |
Array
(
[id] => 16686706
[patent_doc_number] => 20210069181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Compositions And Methods For Reducing Major Adverse Cardiovascular Events
[patent_app_type] => utility
[patent_app_number] => 17/099316
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099316 | Compositions and methods for reducing major adverse cardiovascular events | Nov 15, 2020 | Issued |
Array
(
[id] => 19717288
[patent_doc_number] => 12202811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Compounds for treating prostate cancer
[patent_app_type] => utility
[patent_app_number] => 17/095653
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 12198
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/095653 | Compounds for treating prostate cancer | Nov 10, 2020 | Issued |
Array
(
[id] => 16961490
[patent_doc_number] => 20210212989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => MODULATORS OF GTPASES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/095399
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/095399 | Modulators of GTPases and their use | Nov 10, 2020 | Issued |
Array
(
[id] => 16837776
[patent_doc_number] => 20210145788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Methods of Treating Ascites
[patent_app_type] => utility
[patent_app_number] => 17/090530
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090530 | Methods of Treating Ascites | Nov 4, 2020 | Abandoned |
Array
(
[id] => 16655970
[patent_doc_number] => 20210052606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/082521
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082521 | Non-hormonal steroid modulators of NF-kB for treatment of disease | Oct 27, 2020 | Issued |
Array
(
[id] => 18383387
[patent_doc_number] => 11654151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Storage-stable ready-to-use formulations of tigecycline
[patent_app_type] => utility
[patent_app_number] => 17/075734
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7139
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075734 | Storage-stable ready-to-use formulations of tigecycline | Oct 20, 2020 | Issued |
| 17/074547 | IMMUNOTHERAPY FOR PREVENTION AND EARLY TREATMENTS FOR COVID-19 INFECTION | Oct 18, 2020 | Abandoned |
Array
(
[id] => 16619904
[patent_doc_number] => 20210038557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/071623
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/071623 | Organoarsenic compounds and methods for the treatment of cancer | Oct 14, 2020 | Issued |
Array
(
[id] => 16619903
[patent_doc_number] => 20210038556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/071435
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/071435 | Organoarsenic compounds and methods for the treatment of cancer | Oct 14, 2020 | Issued |
Array
(
[id] => 16748765
[patent_doc_number] => 20210100774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS AND COMPOSITIONS FOR ENHANCING ANTI-TUMOR IMMUNITY BY TARGETING STEROIDOGENESIS
[patent_app_type] => utility
[patent_app_number] => 17/065328
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065328 | Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis | Oct 6, 2020 | Issued |
Array
(
[id] => 17821457
[patent_doc_number] => 11426380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Urolithins as immune response enhancers
[patent_app_type] => utility
[patent_app_number] => 17/061265
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 20619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061265 | Urolithins as immune response enhancers | Sep 30, 2020 | Issued |
Array
(
[id] => 17695917
[patent_doc_number] => 11369619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Composition for curing migraine headaches
[patent_app_type] => utility
[patent_app_number] => 17/034601
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5552
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/034601 | Composition for curing migraine headaches | Sep 27, 2020 | Issued |
Array
(
[id] => 16726451
[patent_doc_number] => 20210093598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => STORAGE STABLE AQUEOUS PARENTERAL SOLUTIONS COMPRISING DICLOFENAC
[patent_app_type] => utility
[patent_app_number] => 17/032395
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032395 | Storage stable aqueous parenteral solutions comprising diclofenac | Sep 24, 2020 | Issued |
Array
(
[id] => 16557054
[patent_doc_number] => 20210002202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Substituted Aromatic Compounds and Pharmaceutical Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/029197
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029197 | Substituted Aromatic Compounds and Pharmaceutical Uses Thereof | Sep 22, 2020 | Abandoned |
Array
(
[id] => 16555632
[patent_doc_number] => 20210000780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS IN THE TREATMENT OF NEOPLASMS
[patent_app_type] => utility
[patent_app_number] => 17/021426
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021426 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS IN THE TREATMENT OF NEOPLASMS | Sep 14, 2020 | Abandoned |
Array
(
[id] => 18012087
[patent_doc_number] => 11504361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Pharmaceutical compositions of therapeutically active compounds
[patent_app_type] => utility
[patent_app_number] => 17/013083
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26329
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013083 | Pharmaceutical compositions of therapeutically active compounds | Sep 3, 2020 | Issued |
Array
(
[id] => 18307240
[patent_doc_number] => 20230111140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => TREATMENT OF PAIN BY TARGETING NR4A1
[patent_app_type] => utility
[patent_app_number] => 17/909513
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909513 | TREATMENT OF PAIN BY TARGETING NR4A1 | Aug 30, 2020 | Pending |
Array
(
[id] => 17441732
[patent_doc_number] => 20220062237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => INJECTABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/006115
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006115 | INJECTABLE FORMULATION | Aug 27, 2020 | Abandoned |
Array
(
[id] => 16671279
[patent_doc_number] => 20210060042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => Patentiflorin A Analogs as Antiviral Agents
[patent_app_type] => utility
[patent_app_number] => 16/947935
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 440
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947935 | Patentiflorin A analogs as antiviral agents | Aug 24, 2020 | Issued |